CD69 and acute myeloid leukemia: Overall, our findings demonstrate that the CD69+ HSC-like leukemic subpopulation is present in various subtypes of AML and is associated with primitive phenotypes, unfavorable genetic backgrounds, and poor clinical outcomes.